GL1X · GenesisL1 explorer

Research workbench

Kpc-2 F72Y mutant with acylated imipenem

Analyse Kpc-2 F72Y mutant with acylated imipenem in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7LLH
Type
protein
Length
520 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Carbapenem-hydrolyzing beta-lactamase kpc
EC
3.5.2.6
UniProt
Q9F663
Ligands
IM2
Pockets
4 · best druggability 0.39

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCarbapenem-hydrolyzing beta-lactamase kpc (EC 3.5.2.6)protein26043% helix, 17% strandQ9F663

Ligands and binding sites

  • IM2 · (5R)-5-[(1S,2R)-1-formyl-2-hydroxypropyl]-3-[(2-{[(E)-iminomethyl]amino}ethyl)sulfanyl]-4,5-dihydro-1H-pyrrole-2-carbox ylic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11180.390.7420empty
2980.380.7618IM2
3640.370.7818empty
41050.370.7519IM2

Interfaces

1 interface between chains.

  • A–B · 394 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent, 2 disulfide (covalent ligand, disulfide).

Compared structures

  • 7LLH · KPC-2 F72Y mutant with acylated imipenem · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9F663 · AlphaFold monomer V2.0 prediction for carbapenem-hydrolyzing beta- lactamase kpc (Q9F663) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.